Healthcare -
Biotechnology - NASDAQ - GB
$ 0.2925
0.245 %
$ 75.4 M
Market Cap
-0.95
P/E
ADAP - TOTAL CURRENT ASSETS
Total Current Assets ADAP - Adaptimmune Therapeutics plc
188 M
LAST VALUE
-14.16%
2 YEAR CAGR
9.33%
5 YEAR CAGR
13.28%
10 YEAR CAGR